Kirin Beverages

Kirin Holdings is a prominent Japanese conglomerate that operates at the intersection of food, beverages, and pharmaceuticals. While its subsidiary Kirin Beverage is a leader in the soft drink market, the group’s life science presence is primarily driven by its pharmaceutical arm, Kyowa Kirin, and its dedicated Health Science business. The company is a global leader in antibody engineering and fermentation technology, with a portfolio featuring blockbuster biologics for rare diseases, oncology, and immunology. Kirin also focuses on functional beverages and nutritional supplements, utilizing proprietary strains like Lactococcus lactis strain Plasma (iMUSE) to target immune health. Through strategic acquisitions like Blackmores and partnerships with global pharma leaders, Kirin continues to expand its footprint in the global healthcare and wellness markets.